血清多配体蛋白聚糖1、血管紧张素转换酶2与川崎病患儿冠状动脉损害和临床疗效的关系OACSTPCD
Relationship between serum syndecan-1,angiotensin-converting enzyme 2 and coronary artery lesions in chil-dren with Kawasaki disease and clinical efficacy
目的 研究血清多配体蛋白聚糖1(syndecan-1,SDC-1)、血管紧张素转换酶2(angiotensin-converting enzyme 2,ACE2)与川崎病(Kawasaki disease,KD)患儿冠状动脉损害(coronary artery lesions,CAL)和临床疗效的关系.方法 选取2020年6月至2022年3月收治的113例KD急性期患儿作为研究对象并设为KD组,治疗前行超声心动图检查,根据检查结果分为CAL组(n=39例)和无CAL组(n=74例);另选取同期体检的60例健康儿童作为对照组.收集受试者临床资料,采用酶联免疫吸附法检测血清SDC-1、ACE2水平并比较.患儿治疗后进行疗效评估,将治愈与好转患儿纳入治疗有效组(n=89例),无效患儿纳入治疗无效组(n=24例).采用多因素logistic回归模型分析患儿治疗无效的影响因素,受试者工作特征(ROC)曲线分析血清SDC-1、ACE2等指标及其联合应用模型对治疗无效的预测价值.结果 KD组血清SDC-1、ACE2水平显著高于对照组(P<0.05).CAL组血清SDC-1、ACE2水平高于无CAL组(P<0.05).治疗有效组与治疗无效组在发热时间、降钙素原(procalcitonin,PCT)、C反应蛋白(C-reactive protein,CRP)、白细胞介素6(interleukin-6,IL-6)、SDC-1、ACE2水平方面比较差异有统计学意义(P<0.05).多因素logistic回归分析显示:PCT、CRP、IL-6、SDC-1、ACE2为患儿治疗无效的显著影响因素(P<0.05).ROC曲线分析显示:血清SDC-1、ACE2两指标联合预测患儿治疗无效的曲线下面积(AUC)(95%CI)为0.837(0.726~0.926),预测价值均高于单独检测.血清SDC-1、ACE2及PCT、CRP、IL-6联合预测患儿治疗无效的AUC(95%CI)为0.903(0.861~0.912),预测价值较血清SDC-1、ACE2两指标联合预测有所提升.结论 KD患儿血清SDC-1、ACE2水平上升,两者水平越高,其并发CAL风险越高,临床疗效越差,联合检测对临床疗效具有较好的预测价值.
Objective To investigate the relationship between serum syndecan-1(SDC-1),angiotensin-converting enzyme 2(ACE2),coronary artery lesions(CAL),and clinical efficacy in children with Kawasaki disease(KD).Methods A total of 113 children with acute KD from June 2020 to March 2022 were enrolled as the KD group.Ultrasonic echocardiography was performed before treatment,and patients were divided into the CAL group(n=39)and non-CAL group(n=74)based on the results.Additionally,60 healthy children who underwent physical examinations at the same period were included as the control group.Clinical data were collected,and serum levels of SDC-1 and ACE2 were detected using enzyme-linked immunosorbent assay.After treatment,efficacy assessment was conducted,with pa-tients classified into the effective treatment group(n=89)and ineffective treatment group(n=24).Multifactor logistic regression analysis was used to identify factors influencing treatment ineffectiveness,and receiver operating characteristic(ROC)curve analysis was performed to evaluate the predictive value of serum SDC-1,ACE2,and their combination for treatment ineffectiveness.Results Serum levels of SDC-1 and ACE2 in the KD group were significantly higher than those in the control group(P<0.05).The CAL group had higher serum levels of SDC-1 and ACE2 as compared to the non-CAL group(P<0.05).There were significant differences in fever duration,procalcitonin(PCT),C-reactive protein(CRP),interleukin-6(IL-6),SDC-1,and ACE2 levels between the effective treatment group and ineffective treatment group(P<0.05).Multifactor logistic regression analysis revealed that PCT,CRP,IL-6,SDC-1,and ACE2 were significant factors influencing treatment ineffectiveness in children with KD(P<0.05).ROC curve analysis showed that the combined prediction of serum SDC-1 and ACE2 for treatment ineffectiveness had an area under the ROC curve(AUC)of 0.837(95%CI:0.726-0.926),which was higher than that of individual tests.The combined predic-tion of serum SDC-1,ACE2,PCT,CRP,and IL-6 for treatment ineffectiveness had an AUC of 0.903(95%CI:0.861-0.912),indicating improved predictive value compared to the combined SDC-1 and ACE2 test alone.Conclu-sion Elevated serum levels of SDC-1 and ACE2 in children with KD are associated with a higher risk of CAL and poorer clinical efficacy.Combined detection of SDC-1 and ACE2 has good predictive value for clinical efficacy.
王从贵;彭海琳;熊伟
成都市青白江区妇幼保健院儿科(四川成都 610306)
临床医学
川崎病多配体蛋白聚糖1血管紧张素转换酶2冠状动脉损害疗效预测价值
Kawasaki diseasesyndecan-1angiotensin converting enzyme 2coronary artery lesionefficacypredictive value
《广东医学》 2024 (006)
666-671 / 6
四川省医学科研课题计划(S2020246)
评论